188 related articles for article (PubMed ID: 2031433)
1. Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.
Fletcher CD; Farish E; Leggate J; Hart DM
Acta Endocrinol (Copenh); 1991 Apr; 124(4):353-6. PubMed ID: 2031433
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen (Premarin) replacement therapy on serum level of total estrogen and urinary excretion of calcium and hydroxyproline in postmenopausal Chinese women.
Ouyang PC; Chow SN; Huang SC; Hsieh CY
Proc Natl Sci Counc Repub China B; 1986 Jul; 10(3):162-6. PubMed ID: 3022320
[TBL] [Abstract][Full Text] [Related]
4. [Calcium-phosphorus metabolism and bone metabolism in postmenopausal patients with the thyroid gland pathology].
Esedova AE; Gadzhieva MM; Ferzilaeva RA
Klin Lab Diagn; 2002 Mar; (3):13-6. PubMed ID: 11980136
[TBL] [Abstract][Full Text] [Related]
5. Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats.
Kim MS; Lee YS
J Med Food; 2005; 8(4):439-45. PubMed ID: 16379553
[TBL] [Abstract][Full Text] [Related]
6. The effect of intranasal salmon calcitonin on biochemical parameters of bone turnover in postmenopausal women.
Balint-Perić LA; Prelević GM; Beslagić Z; Petrović J
Gynecol Endocrinol; 1994 Dec; 8(4):241-5. PubMed ID: 7709763
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin, estrogens and the bone.
Gennari C; Agnusdei D
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):451-5. PubMed ID: 2257249
[TBL] [Abstract][Full Text] [Related]
8. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
9. The effect of ethinyl oestradiol on calcium and bone metabolism in peri- and postmenopausal women.
Marshall RW; Selby PL; Chilvers DC; Hodgkinson A
Horm Metab Res; 1984 Feb; 16(2):97-9. PubMed ID: 6706290
[TBL] [Abstract][Full Text] [Related]
10. Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis.
Pietschmann P; Resch H; Krexner E; Woloszczuk W; Willvonseder R
Acta Med Austriaca; 1991; 18(5):114-6. PubMed ID: 1796722
[TBL] [Abstract][Full Text] [Related]
11. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
Overgaard K; Hansen MA; Nielsen VA; Riis BJ; Christiansen C
Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594
[TBL] [Abstract][Full Text] [Related]
12. [Effect of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate].
Campusano C; López JM; Campino C; Cárdenas I; Rojas A
Rev Med Chil; 2000 Apr; 128(4):387-91. PubMed ID: 10962855
[TBL] [Abstract][Full Text] [Related]
13. Prevention of bone mineral loss in postmenopausal women by norethisterone.
Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
[TBL] [Abstract][Full Text] [Related]
14. The effect of hormone replacement therapy on postmenopausal bone loss.
Castelo-Branco C; Martínez de Osaba MJ; Pons F; González-Merlo J
Eur J Obstet Gynecol Reprod Biol; 1992 Apr; 44(2):131-6. PubMed ID: 1587378
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
[TBL] [Abstract][Full Text] [Related]
16. Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis.
Overgaard K; Hansen MA; Dirksen KL; Christiansen C
Calcif Tissue Int; 1992 Sep; 51(3):184-8. PubMed ID: 1422962
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal bone loss: does HRT always work?
Stevenson JC; Hillard TC; Lees B; Whitcroft SI; Ellerington MC; Whitehead MI
Int J Fertil Menopausal Stud; 1993; 38 Suppl 2():88-91. PubMed ID: 8252111
[TBL] [Abstract][Full Text] [Related]
18. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.
Christiansen C; Christensen MS; Larsen NE; Transbøl IB
J Clin Endocrinol Metab; 1982 Dec; 55(6):1124-30. PubMed ID: 7130340
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.
Vural P; Akgul C; Canbaz M
Pharmacol Res; 2006 Oct; 54(4):298-302. PubMed ID: 16879975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
